Zibo Qixiang Tengda Chemical Co., Ltd
002408.SZ · SHZ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 29.81B | 2.57B | 748.29M | 633.88M | 0.22 |
| 2023 FY | 26.92B | 1.60B | -261.52M | -383.67M | -0.13 |
| 2024 FY | 25.22B | 1.39B | 38.09M | 31.68M | 0.01 |
| 2025 FY | 23.77B | 763.41M | -638.09M | -574.53M | -0.20 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 29.00B | 14.91B | 2.61B | 8.28B | 13.49B |
| 2023 FY | 26.78B | 14.47B | 3.11B | 9.04B | 11.80B |
| 2024 FY | 25.36B | 13.48B | 2.90B | 9.85B | 11.67B |
| 2025 FY | 24.52B | 13.30B | 3.19B | 9.21B | 11.07B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 1.46B | -4.63B | -3.17B | -810.42M | -446.77M |
| 2023 FY | 660.87M | -2.31B | -1.65B | -454.85M | 281.09M |
| 2024 FY | 1.35B | -752.82M | 599.29M | -368.53M | 542.04M |
| 2025 FY | 1.30B | -632.43M | 670.38M | -261.56M | 523.29M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 20.01B | 25.68B | — | — | — |
| 2023 FY | 15.58B | 21.51B | — | — | — |
| 2024 FY | 14.18B | 21.13B | — | — | — |
| 2025 FY | 14.02B | 20.05B | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 6.59B | 340.54M | 23.31M | 17.75M | 0.01 |
| 2025 Q3 | 6.00B | 154.02M | -124.69M | -168.93M | -0.06 |
| 2025 Q4 | 5.56B | -4.97M | -405.70M | -428.75M | -0.15 |
| 2026 Q1 | 5.89B | 283.90M | -99.81M | -91.63M | -0.03 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 25.02B | 13.20B | 3.11B | 10.13B | 11.67B |
| 2025 Q3 | 24.74B | 13.08B | 2.88B | 10.65B | 11.52B |
| 2025 Q4 | 24.52B | 13.30B | 3.19B | 9.21B | 11.07B |
| 2026 Q1 | 25.55B | 14.47B | 3.14B | 10.91B | 11.00B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 598.69M | -621.03M | -22.33M | -126.34M | 352.81M |
| 2025 Q3 | 104.61M | 97.50M | 202.11M | -57.00M | -233.15M |
| 2025 Q4 | 357.39M | 103.08M | 460.46M | -34.20M | 400.92M |
| 2026 Q1 | 245.47M | -145.45M | 100.03M | -37.04M | 296.47M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 12.63B | 19.66B | — | — | — |
| 2025 Q3 | 13.59B | 21.36B | — | — | — |
| 2025 Q4 | 14.02B | 20.05B | — | — | — |
| 2026 Q1 | 16.95B | 24.73B | — | — | — |